Lawrence Lemak, MD
Orthopaedic Surgery · Vestavia, ALNPI 1851368757
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $173,058 of the $216,197 with a category attached, or 80.0%. Anika Therapeutics, Inc. accounts for 98.5% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2020 at $175,138 and has fallen 99.8% since, to $330 in 2025. Among orthopaedic surgery clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $3860.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$213K
- Maruho Medical, Inc.$2K
- Johnson & Johnson$452
- Pacira Pharmaceuticals Incorporated$195
- Smith+Nephew$86
- Pacira Therapeutics, Inc.$78
- plus $391 from 16 others
What the payments were for
- Consulting fees$2,0001%
- Food & beverage$1,2301%
- Ownership interest$173,05880%
- Other$39,90918%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 5 | $212,994 |
| Maruho Medical, Inc. | 1 | $2,000 |
| Johnson & Johnson(2 entities) | 15 | $452 |
| Pacira Pharmaceuticals Incorporated | 9 | $195 |
| Smith+Nephew | 2 | $86 |
| Pacira Therapeutics, Inc. | 4 | $78 |
| Bioventus LLC | 2 | $43 |
| Heraeus Medical, LLC. | 1 | $41 |
| Abbott | 2 | $38 |
| Convatec Inc. | 1 | $30 |
| Si-bone, Inc. | 2 | $28 |
| Solventum Corporation | 1 | $28 |
| Dexcom, Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Orthofix Medical, Inc. | 2 | $20 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $18 |
| ERMI LLC | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Zimmer Biomet | 1 | $15 |
| Baudax Bio Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Accessories$2,000
How this compares
$216,197 in reported general payments places this provider in the 95th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 78 | $444 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 44 | $325 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $280 |
| Methocarbamol | 29 | $246 |
| Meloxicam | 54 | $177 |
| Tramadol Hcl | 29 | $61 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Vestavia
- Scott AppellVestavia$30K
- Jeffrey DugasBirmingham$11.5M
- Benton EmblomBirmingham$3M
- Herrick SiegelBirmingham$1.2M
- Paul CanaleDaphne$609K
- Kenneth MooreBirmingham$342K
- Joseph SherrillBirmingham$221K
- Jonathan QuadeBirmingham$217K
- Ginger BryantBirmingham$209K
- Marcus RothermichBirmingham$207K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.